BrightSpring Health Services, Inc.
For the period ended Sep 30, 2026. Filed Oct 30, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Oct 30, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Shareholders’ Equity
(In thousands, except share data)
| Common Stock · Additional Paid-In Capital · Retained Earnings · Accumulated Other Comprehensive Income · NoncontrollingInterest · Total | |||||||
|---|---|---|---|---|---|---|---|
| Shares · Amount | |||||||
| Balances at June 30, 2026 | 197,509,491 | $1,975 | $2,004,123 | $38,434 | $4,185 | $68 | $2,048,785 |
| Net income (1) | — | — | — | 100,138 | — | 7 | 100,145 |
| Other comprehensive income, net of tax | — | — | — | — | 9,914 | — | 9,914 |
| Share-based compensation | — | — | 17,871 | — | — | — | 17,871 |
| Exercise of stock options | 412,175 | 4 | 4,837 | — | — | — | 4,841 |
| Issuance of common stock for settlement of RSUs | 175,950 | 1 | (1) | — | — | — | — |
| Tax effect of net share settlement of equity awards | (70,160) | — | (4,941) | — | — | — | (4,941) |
| Conversion of tangible equity units into common stock | 786,864 | 8 | (8) | — | — | — | — |
| Balances at September 30, 2026 | 198,814,320 | $1,988 | $2,021,881 | $138,572 | $14,099 | $75 | $2,176,615 |
| Common Stock · Additional Paid-In Capital · Accumulated Deficit · Accumulated Other Comprehensive Loss · NoncontrollingInterest · Total | |||||||
|---|---|---|---|---|---|---|---|
| Shares · Amount | |||||||
| Balances at June 30, 2025 | 177,055,327 | $1,771 | $1,909,854 | $(164,405) | $(4,330) | $(283) | $1,742,607 |
| Net income (loss) (1) | — | — | — | 55,836 | — | (140) | 55,696 |
| Other comprehensive loss, net of tax | — | — | — | — | (1,961) | — | (1,961) |
| Share-based compensation | — | — | 17,250 | — | — | — | 17,250 |
| Exercise of stock options | 735,483 | 7 | 5,612 | — | — | — | 5,619 |
| Issuance of common stock for settlement of RSUs | 115,810 | 1 | (1) | — | — | — | — |
| Tax effect of net share settlement of equity awards | (52,203) | — | (1,071) | — | — | — | (1,071) |
| Conversion of tangible equity units into common stock | 2,831,467 | 28 | (28) | — | — | — | — |
| Other | — | — | — | — | — | 517 | 517 |
| Balances at September 30, 2025 | 180,685,884 | $1,807 | $1,931,616 | $(108,569) | $(6,291) | $94 | $1,818,657 |
(1) Net income (loss) to the Company for the three months ended September 30, 2026 and 2025 excludes$154 and$(455), respectively, allocable to the redeemable noncontrolling interests for our joint venture arrangements.
Condensed Consolidated Statements of Shareholders’ Equity (continued)
(In thousands, except share data)
| Common Stock · Additional Paid-In Capital · (Accumulated Deficit) Retained Earnings · Accumulated Other Comprehensive (Loss) Income · NoncontrollingInterest · Total | |||||||
|---|---|---|---|---|---|---|---|
| Shares · Amount | |||||||
| Balances at December 31, 2025 | 192,124,125 | $1,921 | $1,954,482 | $(74,647) | $(6,691) | $74 | $1,875,139 |
| Net income (1) | — | — | — | 333,195 | — | 14 | 333,209 |
| Other comprehensive income, net of tax | — | — | — | — | 20,790 | — | 20,790 |
| Share-based compensation | — | — | 41,040 | — | — | — | 41,040 |
| Exercise of stock options | 4,352,198 | 43 | 37,213 | — | — | — | 37,256 |
| Issuance of common stock for settlement of RSUs | 1,748,824 | 17 | (17) | — | — | — | — |
| Tax effect of net share settlement of equity awards | (232,565) | (2) | (11,546) | — | — | — | (11,548) |
| Conversion of tangible equity units into common stock | 3,313,010 | 33 | (33) | — | — | — | — |
| Share repurchases | (2,491,272) | (24) | — | (119,976) | — | — | (120,000) |
| Other | — | — | 742 | — | — | (13) | 729 |
| Balances at September 30, 2026 | 198,814,320 | $1,988 | $2,021,881 | $138,572 | $14,099 | $75 | $2,176,615 |
| Common Stock · Additional Paid-In Capital · Accumulated Deficit · Accumulated Other Comprehensive Income (Loss) · NoncontrollingInterest · Total | |||||||
|---|---|---|---|---|---|---|---|
| Shares · Amount | |||||||
| Balances at December 31, 2024 | 174,245,990 | $1,742 | $1,866,850 | $(222,155) | $1,418 | $— | $1,647,855 |
| Net income (loss) (1) | — | — | — | 113,586 | — | (423) | 113,163 |
| Other comprehensive loss, net of tax | — | — | — | — | (7,709) | — | (7,709) |
| Share-based compensation | — | — | 55,733 | — | — | — | 55,733 |
| Exercise of stock options | 2,055,618 | 21 | 14,660 | — | — | — | 14,681 |
| Issuance of common stock for settlement of RSUs | 1,817,356 | 18 | (18) | — | — | — | — |
| Tax effect of net share settlement of equity awards | (264,547) | (2) | (5,581) | — | — | — | (5,583) |
| Conversion of tangible equity units into common stock | 2,831,467 | 28 | (28) | — | — | — | — |
| Other | — | — | — | — | — | 517 | 517 |
| Balances at September 30, 2025 | 180,685,884 | $1,807 | $1,931,616 | $(108,569) | $(6,291) | $94 | $1,818,657 |
(1) Net income (loss) to the Company for the nine months ended September 30, 2026 and 2025 excludes($91) and$(1,370), respectively, allocable to the redeemable noncontrolling interests for our joint venture arrangements.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.